Moderna, Inc. (MRNA)
138.82
-6.31
(-4.35%)
USD |
NASDAQ |
Aug 24, 16:00
139.00
+0.18
(+0.13%)
After-Hours: 20:00
Moderna Profit Margin (Quarterly) : -539.3% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -539.3% |
| March 31, 2026 | -345.2% |
| December 31, 2025 | -121.8% |
| September 30, 2025 | -19.68% |
| June 30, 2025 | -581.0% |
| March 31, 2025 | -899.1% |
| December 31, 2024 | -115.9% |
| September 30, 2024 | 0.70% |
| June 30, 2024 | -530.7% |
| March 31, 2024 | -703.6% |
| December 31, 2023 | 7.74% |
| September 30, 2023 | -198.3% |
| June 30, 2023 | -401.2% |
| March 31, 2023 | 4.22% |
| December 31, 2022 | 29.16% |
| September 30, 2022 | 31.47% |
| June 30, 2022 | 46.56% |
| March 31, 2022 | 60.43% |
| Date | Value |
|---|---|
| December 31, 2021 | 68.16% |
| September 30, 2021 | 67.08% |
| June 30, 2021 | 63.85% |
| March 31, 2021 | 63.04% |
| December 31, 2020 | -47.74% |
| September 30, 2020 | -148.0% |
| June 30, 2020 | -175.9% |
| March 31, 2020 | -1.48K% |
| December 31, 2019 | -884.0% |
| September 30, 2019 | -722.8% |
| June 30, 2019 | -1.03K% |
| March 31, 2019 | -827.3% |
| December 31, 2018 | -399.3% |
| September 30, 2018 | -192.4% |
| June 30, 2018 | -314.0% |
| March 31, 2018 | -249.2% |
| December 31, 2017 | -41.29% |
| September 30, 2017 | -152.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioNTech SE | -777.3% |
| Kailera Therapeutics, Inc. | -- |
| Sarepta Therapeutics, Inc. | -1.22% |
| Replimune Group, Inc. | -- |
| Intellia Therapeutics, Inc. | -1.39K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.92% |
| Return on Assets | -26.73% |
| Return on Invested Capital | -33.58% |
| Gross Profit Margin (Quarterly) | -7.59% |
| Operating Margin (Quarterly) | -562.1% |
| Return on Net Operating Assets | -86.34% |